Popular Articles
Burdock Root

MDRNA, Inc. Receives Full FDA Approval Of Generic Calcitonin-Salmon Nasal Spray For Osteoporosis
MDRNA, Inc. (NASDAQ: MRNA) announced that it has obtained full U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for generic calcitonin-salmon nasal spray for the treatment of osteoporosis and that Par Pharmaceutical Companies, Inc. (NYSE: PAR) has launched the product.
generic viagra online
What Is Strep Throat? What Is Sore Throat?
Strep throat is a sore throat caused by bacteria known as Streptococcus pyogenes, or group A streptococcus. Sore throat is a term for any situation where the throat feels scratchy, tender, and possibly painful. Strep throat is a type of sore throat. Sore throat may be caused by bacteria or viruses, while strep throat is only caused by bacteria. The term strep throat is more commonly used in the USA and Canada, compared to other English speaking countries. Strep throat may also be referred to as Streptococcal pharyngitis or streptococcal sore throat.
News of the day
Reducing P38MAPK Levels Delays Aging Of Multiple Tissues In Lab Mice
In the new issue of the Developmental Cell journal, a team of scientists at Singapore"s Agency for Science, Technology and Research (A*STAR) and the University of North Carolina School of Medicine at Chapel Hill, report research findings about the molecular mechanisms behind the aging process, which has up till now been poorly understood, that offer the possibility that a novel, pharmacological approach could be developed to combat age-related disorders.
Health Insurance

Improving The Biomarker Pipeline For Early Cancer Detection

Several statistical and biological issues need to be addressed in order to improve biomarker identification for early detection of cancer, according to a commentary published online July 2 in the Journal of the National Cancer Institute. The biomarker pipeline to develop and evaluate cancer screening tests includes the identification of promising biomarkers to detect cancers early and the initial and definitive evaluation of biomarkers for cancer screening. In the commentary, Stuart G. Baker, ScD, of the National Cancer Institute in Bethesda, Md., discusses the various ways to improve this pipeline, including the need for more frequent specimen collection to help identify promising biomarkers and the use of the paired availability design, in which data are collected on the number of interval cases associated with screening in time periods before and after the introduction of the new biomarker test. "ò€¦[S]ome important design and analysis considerations related to this biomarker pipeline have been underappreciated, insufficiently disseminated, or not previously discussed," the author writes. "By taking these considerations into account, researchers can improve this biomarker pipeline." Steve Graff Journal of the National Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):